Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009 –2018
ConclusionPatients in the Middle East enrolled in a large multinational registry are representative of the general MS population. The spectrum of therapies used in the individual countries, however, is highly variable. Further studies that include rural and non-academic practices are needed to enhance our understanding of the MS cohorts in the Middle East.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Academia | Disability | Egypt Health | Epidemiology | Iran Health | Kuwait Health | Lebanon Health | Middle East Health | Multiple Sclerosis | Neurology | Oman Health | Rural Health | Saudi Arabia Health | Statistics | Study | Turkey Health | UAE Health